Jungersted JM et al. |
Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. |
2011 |
Acta Derm. Venereol. |
pmid:21365172
|
Quist SR et al. |
Effects of Topical Tacrolimus and Polyunsaturated Fatty Acids on In Vivo Release of Eicosanoids in Atopic Dermatitis During Dermal Microdialysis. |
2016 |
Acta Derm. Venereol. |
pmid:26911315
|
Zattra E et al. |
Labial melanotic macule after application of topical tacrolimus: two case reports. |
2010 |
Acta Derm. Venereol. |
pmid:20814635
|
Hartmann A et al. |
Treatment of generalised vitiligo with tacrolimus 0.1% ointment vs. UVB intense pulsed light phototherapy: a pilot study. |
2014 |
Acta Derm. Venereol. |
pmid:24473666
|
Granlund H et al. |
Treatment of lichenified atopic eczema with tacrolimus ointment. |
2001 Aug-Sep |
Acta Derm. Venereol. |
pmid:11720192
|
Hao D et al. |
Lymphocytic infiltration of the eyelid: two cases responding to tacrolimus and topical glucocorticoid. |
2013 |
Acta Derm. Venereol. |
pmid:23423497
|
Mandelin J et al. |
Leg ulcers treated with topical tacrolimus in patients with rheumatoid arthritis. |
2010 |
Acta Derm. Venereol. |
pmid:21057750
|
Nakamizo S et al. |
Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1% topical tacrolimus and gabapentin. |
2010 |
Acta Derm. Venereol. |
pmid:21057761
|
Mandelin J et al. |
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. |
2010 |
Acta Derm. Venereol. |
pmid:20169301
|
Ujiie H et al. |
Successful treatment of nail lichen planus with topical tacrolimus. |
2010 |
Acta Derm. Venereol. |
pmid:20169322
|
Inoue T et al. |
Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. |
2006 |
Acta Derm. Venereol. |
pmid:16585982
|
Ortonne JP et al. |
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. |
2006 |
Acta Derm. Venereol. |
pmid:16585986
|
Tzung TY et al. |
Pimecrolimus and narrowband UVB as monotherapy or combination therapy in children and adolescents with atopic dermatitis. |
2006 |
Acta Derm. Venereol. |
pmid:16585987
|
Pitarch G et al. |
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. |
2006 |
Acta Derm. Venereol. |
pmid:16585995
|
Cunha PR |
Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. |
2006 |
Acta Derm. Venereol. |
pmid:16585998
|
Cunha PR and Rossi AB |
Pimecrolimus cream 1% is effective in a case of granulomatous rosacea. |
2006 |
Acta Derm. Venereol. |
pmid:16585999
|
Ambo M |
Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. |
2002 |
Acta Derm. Venereol. |
pmid:12353724
|
Chittock J et al. |
Comparing the Effect of a Twice-weekly Tacrolimus and Betamethasone Valerate Dose on the Subclinical Epidermal Barrier Defect in Atopic Dermatitis. |
2015 |
Acta Derm. Venereol. |
pmid:25594610
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Kim TW et al. |
Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial. |
2013 |
Acta Derm. Venereol. |
pmid:23388687
|